Nanosyn
Biotechnology ResearchCalifornia, United States11-50 Employees
Nanosyn is a biotechnology research company headquartered in Santa Clara, California, at 3100 Central Expressway. It offers chemistry-on-demand services, including made-to-order focused compound libraries, hit-to-lead optimization, and medicinal chemistry services, to support drug discovery. The company reports proprietary chemistry technology aimed at accelerating drug discovery for biotechnology and pharmaceutical companies globally, with operations dating back to 1998. The organization employs between 11 and 50 people and has pursued facility expansions, such as a California expansion in 2019 and the opening of a San Diego facility in 2017; it has had a collaboration with FORMA Therapeutics in 2014. In 2021, Element Materials Technology acquired Nanosyn Inc., indicating a change in ownership.